The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The Mechanism of Inhibition of Antibody-based Inhibitors of Membrane-type Serine Protease 1 (MT-SP1)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-affinity binders selected from designed ankyrin repeat protein libraries
Binz, H. K., Amstutz, P., Kohl, A., Stumpp, M. T., Briand, C., Forrer, P., Grütter, M. G., & Plückthun, A. (2004) · Nature Biotechnology · doi:10.1038/nbt962 · Cited by 656
Fukuoka, Y., & Schwartz, L. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3165 · Cited by 35
Research works printed but not linked: 43
- Rawlings, 2006, MEROPS: the peptidase database, Nucl. Acids Res., 34, D270, 10.1093/nar/gkj089 · DOI · Paper page
- Laskowski, 1980, Protein inhibitors of proteinases, Annu. Rev. Biochem., 49, 593, 10.1146/annurev.bi.49.070180.003113 · DOI · Paper page
- Eggers, 2001, The role of ecotin dimerization in protease inhibition, J. Mol. Biol., 308, 975, 10.1006/jmbi.2001.4754 · DOI
- Tyndall, 2005, Proteases universally recognize beta strands in their active sites, Chem. Rev., 105, 973, 10.1021/cr040669e · DOI · Paper page
- Rydel, 1991, Refined structure of the hirudin-thrombin complex, J. Mol. Biol., 221, 583, 10.1016/0022-2836(91)80074-5 · DOI · Paper page
- Castro, 1996, Alanine point-mutations in the reactive region of bovine pancreatic trypsin inhibitor: effects on the kinetics and thermodynamics of binding to beta-trypsin and alpha-chymotrypsin, Biochemistry, 35, 11435, 10.1021/bi960515w · DOI
- Coussens, 2002, Matrix metalloproteinase inhibitors and cancer: trials and tribulations, Science, 295, 2387, 10.1126/science.1067100 · DOI · Paper page
- Dennis, 2000, Peptide exosite inhibitors of factor VIIa as anticoagulants, Nature, 404, 465, 10.1038/35006574 · DOI · Paper page
- Roberge, 2001, A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors, Biochemistry, 40, 9522, 10.1021/bi010592d · doi:10.1021/bi010592d
- Krook, 1997, Selection of a cyclic nonapeptide inhibitor to alpha-chymotrypsin using a phage display peptide library, Mol. Divers., 3, 149, 10.1023/A:1009697515328 · DOI
- Hansen, 2005, A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition, J. Biol. Chem., 280, 38424, 10.1074/jbc.M505933200 · DOI
- Wang, 1995, Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage display of ecotin, J. Biol. Chem., 270, 12250, 10.1074/jbc.270.20.12250 · DOI
- Dennis, 1994, Kunitz domain inhibitors of tissue factor-factor VIIa. II. Potent and specific inhibitors by competitive phage selection, J. Biol. Chem., 269, 22137, 10.1016/S0021-9258(17)31766-0 · doi:10.1016/s0021-9258(17)31766-0
- Stoop, 2003, Engineering of a macromolecular scaffold to develop specific protease inhibitors, Nature Biotechnol., 21, 1063, 10.1038/nbt860 · DOI
- Rezacova, 2001, Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody, Structure, 9, 887, 10.1016/S0969-2126(01)00654-2 · doi:10.1016/s0969-2126(01)00654-2
- Puchi, 2006, Microinjection of an antibody against the cysteine-protease involved in male chromatin remodeling blocks the development of sea urchin embryos at the initial cell cycle, J. Cell Biochem., 98, 335, 10.1002/jcb.20800 · doi:10.1002/jcb.20800
- Petersen, 2001, Localization of epitopes for monoclonal antibodies to urokinase-type plasminogen activator: relationship between epitope localization and effects of antibodies on molecular interactions of the enzyme, Eur. J. Biochem., 268, 4430, 10.1046/j.1432-1327.2001.02365.x · doi:10.1046/j.1432-1327.2001.02365.x
- Matias-Roman, 2005, Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium, Blood, 105, 3956, 10.1182/blood-2004-06-2382 · DOI
- Xuan, 2006, Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture, Cancer Res., 66, 3611, 10.1158/0008-5472.CAN-05-2983 · doi:10.1158/0008-5472.can-05-2983
- Obermajer, 2006, Carboxypeptidase cathepsin X mediates beta2-integrin-dependent adhesion of differentiated U-937 cells, Expt. Cell Res., 312, 2515, 10.1016/j.yexcr.2006.04.019 · DOI
- Maun, 2003, Engineering exosite peptides for complete inhibition of factor VIIa using a protease switch with substrate phage, J. Biol. Chem., 278, 21823, 10.1074/jbc.M300951200 · doi:10.1074/jbc.m300951200
- Sun, 2003, Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies, Biochemistry, 42, 892, 10.1021/bi026878f · doi:10.1021/bi026878f
- Takeuchi, 1999, Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue, Proc. Natl Acad. Sci. USA, 96, 11054, 10.1073/pnas.96.20.11054 · doi:10.1073/pnas.96.20.11054
- Lin, 1999, Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk, J. Biol. Chem., 274, 18237, 10.1074/jbc.274.26.18237 · doi:10.1074/jbc.274.26.18237
- Uhland, 2006, Matriptase and its putative role in cancer, Cell Mol. Life Sci., 63, 2968, 10.1007/s00018-006-6298-x · DOI · Paper page
- List, 2005, Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation, Genes Dev., 19, 1934, 10.1101/gad.1300705 · DOI · Paper page
- Knappik, 2000, Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides, J. Mol. Biol., 296, 57, 10.1006/jmbi.1999.3444 · DOI · Paper page
- Morrison, 1988, The behavior and significance of slow-binding enzyme inhibitors, Advan. Enzymol. Relat. Areas Mol. Biol., 61, 201
- Williams, 1979, The kinetics of reversible tight-binding inhibition, Methods Enzymol., 63, 437, 10.1016/0076-6879(79)63019-7 · DOI · Paper page
- Evans, 1982, p-Aminobenzamidine as a fluorescent probe for the active site of serine proteases, J. Biol. Chem., 257, 3014, 10.1016/S0021-9258(19)81066-9 · doi:10.1016/s0021-9258(19)81066-9
- Parry, 1994, Kinetic mechanism for the interaction of Hirulog with thrombin, Biochemistry, 33, 14807, 10.1021/bi00253a020 · doi:10.1021/bi00253a020
- Fernandez, 1999, Draculin, the anticoagulant factor in vampire bat saliva, is a tight-binding, noncompetitive inhibitor of activated factor X, Biochim. Biophys. Acta, 1434, 135, 10.1016/S0167-4838(99)00160-0 · doi:10.1016/s0167-4838(99)00160-0
- Ozawa, 1966, The reactive site of trypsin inhibitors, J. Biol. Chem., 241, 3955, 10.1016/S0021-9258(18)99798-X · doi:10.1016/s0021-9258(18)99798-x
- McGrath, 1991, The sequence and reactive site of ecotin. A general inhibitor of pancreatic serine proteases from Escherichia coli, J. Biol. Chem., 266, 6620, 10.1016/S0021-9258(18)38162-6 · DOI
- Cunningham, 1989, High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis, Science, 244, 1081, 10.1126/science.2471267 · DOI · Paper page
- Friedrich, 2002, Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinase, J. Biol. Chem., 277, 2160, 10.1074/jbc.M109830200 · doi:10.1074/jbc.m109830200
- Luthy, 1973, Detailed mechanism of interaction of bovine-trypsin with soybean trypsin inhibitor (Kunitz). I. Stopped flow measurements, J. Biol. Chem., 248, 1760, 10.1016/S0021-9258(19)44256-7 · doi:10.1016/s0021-9258(19)44256-7
- Schreiber, 1996, Rapid, electrostatically assisted association of proteins, Nature Struct. Biol., 3, 427, 10.1038/nsb0596-427 · DOI · Paper page
- Rezaie, 2004, Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism, Biochemistry, 43, 3368, 10.1021/bi036177y · doi:10.1021/bi036177y
- Martin, 1997, Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease, Protein Eng., 10, 607, 10.1093/protein/10.5.607 · DOI
- Bhatt, 2007, Coordinate expression and functional profiling identify and extracellular proteolytic signaling pathway, Proc. Natl Acad. Sci. USA, 104, 5771, 10.1073/pnas.0606514104 · doi:10.1073/pnas.0606514104
- Jameson, 1973, Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration, Biochem. J., 131, 107, 10.1042/bj1310107 · DOI · Paper page
- Chou, 1974, Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition, Mol. Pharmacol., 10, 235
Cited by
Targeting MET in cancer: rationale and progress
Gherardi, E., Birchmeier, W., Birchmeier, C., & Woude, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3205 · Cited by 1,423
A structure‐based benchmark for protein–protein binding affinity
Kastritis, P. L., Moal, I. H., Hwang, H., Weng, Z., Bates, P. A., Bonvin, A. M. J. J., & Janin, J. (2011) · Protein Science · doi:10.1002/pro.580 · Cited by 313
Moal, I. H., & Fernández-Recio, J. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts489 · Cited by 281
Metadata
- Authors
- Farady, C. J., Sun, J., Darragh, M. R., Miller, S. M., & Craik, C. S.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 369
- Issue
- 4
- Pages
- 1041-1051
- ISSN
- 0022-2836
- Cited by
- 50
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Mechanism of Inhibition of Antibody-based Inhibitors of Membrane-type Serine Protease 1 (MT-SP1). https://app.cochat.ai/papers/10.1016/j.jmb.2007.03.078
- The paper
- Farady, C. J., Sun, J., Darragh, M. R., Miller, S. M., & Craik, C. S. (2007). The Mechanism of Inhibition of Antibody-based Inhibitors of Membrane-type Serine Protease 1 (MT-SP1). Journal of Molecular Biology. https://doi.org/10.1016/j.jmb.2007.03.078
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.